Clinical trial
Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing…
NCT01802411 · Pacira Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT01802411 |
|---|---|
| Title | Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy |
| Official title | A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Assess the Efficacy and Safety of Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy |
| Lead sponsor | Pacira Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Posterolateral Thoracotomy, Postoperative Pain |
| Intervention type | Drug |
| Interventions | EXPAREL 266 mg, Placebo |
| Enrollment | 191 |
| Start date | Dec 1, 2012 |
| Primary completion | Jun 1, 2013 |
| Completion | Jun 1, 2013 |
| First posted | Mar 1, 2013 |
| Last update posted | Jul 12, 2021 |
| Countries | Bulgaria, Czechia, Georgia, Poland, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: